Toggle navigation
Home
Search
Services
Blog
Contact
About
Monoclone Antibodies Against Progestin Receptor Isoforms
Anderson, Thomas R.
Berkeley Antibody Company, Richmond, CA, United States
Search 127 grants from Thomas Anderson
Search grants from Berkeley Antibody Company
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular analysis of variable drug resistance in Candida lusitaniae isolates
Ibudilast Phase II trial in progressive MS
Acid Adaptation Targets for Eradication of Helicobacter pylori
Clinical Research Skills Development
Recently added grants:
Social Processing Systems in Veterans with Schizophrenia: Identifying Deficits in Brain Activation and Network Organization
Brain Bioenergetic Response to Hypoxic Stress in Bipolar Disorder
Convergent Genetic and Genomic Analyses of Schizophrenia
Surgical Studies on the Role of MicroRNAs in Esophageal Cancer
Parenchymal and airway CD4+ T cells in protection against pulmonary tuberculosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43DK012277-001
Application #
3637978
Study Section
Project Start
1991-08-01
Project End
1992-04-30
Budget Start
1992-03-26
Budget End
1992-01-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Berkeley Antibody Company
Department
Type
DUNS #
City
Richmond
State
CA
Country
United States
Zip Code
94806
Related projects
NIH 1992
N43 DK
Monoclone Antibodies Against Progestin Receptor Isoforms
Anderson, Thomas R. / Berkeley Antibody Company
NIH 1991
N43 DK
Monoclone Antibodies Against Progestin Receptor Isoforms
Anderson, Thomas R. / Berkeley Antibody Company
Comments
Be the first to comment on Thomas Anderson's grant